Most Down Articles

Published in last 1 year | In last 2 years| In last 3 years| All| Most Downloaded in Recent Month | Most Downloaded in Recent Year|

In last 2 years

Please wait a minute...


For Selected: Download Citations EndNote Reference Manager ProCite BibTeX RefWorks Toggle Thumbnails

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (22): 3-6.   Abstract （49）      PDF （252KB）（368）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (26): 81-83.   Abstract （44）      PDF （757KB）（231）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (21): 9-12.   Abstract （49）      PDF （768KB）（204）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (31): 90-92.   Abstract （22）      PDF （746KB）（199）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (23): 41-43.   Abstract （43）      PDF （614KB）（194）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (21): 91-92.   Abstract （43）      PDF （820KB）（183）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (18): 6-8.   Abstract （373）      PDF （309KB）（169）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2024, 14 (1): 78-80.   Abstract （53）      PDF （841KB）（155）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (18): 65-67.   Abstract （53）      PDF （715KB）（133）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (22): 79-81.   Abstract （35）      PDF （737KB）（131）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 31-33.   Abstract （29）      PDF （526KB）（129）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (22): 33-35.   Abstract （36）      PDF （584KB）（124）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 34-36.   Abstract （30）      PDF （528KB）（122）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 28-30.   Abstract （24）      PDF （502KB）（119）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (21): 45-47.   Abstract （45）      PDF （639KB）（119）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (18): 27-29.   Abstract （47）      PDF （503KB）（116）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (21): 93-96.   Abstract （63）      PDF （789KB）（114）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2024, 14 (4): 139-144.   Abstract （106）      PDF （866KB）（113）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (18): 12-14.   Abstract （27）      PDF （394KB）（109）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (19): 20-22.   Abstract （40）      PDF （1005KB）（108）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 46-49.   Abstract （41）      PDF （651KB）（107）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 37-39.   Abstract （30）      PDF （571KB）（106）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (19): 47-50.   Abstract （46）      PDF （680KB）（104）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (26): 33-35.   Abstract （33）      PDF （634KB）（104）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (21): 81-83.   Abstract （55）      PDF （806KB）（101）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 24-27.   Abstract （24）      PDF （504KB）（99）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Rehabilitationeffect of walking training in patients with lower limb arteriosclerosis obliterans HUANG Li-ping, YU Yan, RUAN Qiang, JI Lin, GUO Wei-chang Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 16-19.   Abstract （36）      PDF （427KB）（94）       Knowledge map    Save Objective To investigate the rehabilitation effect of walking training in patients with lower limb arteriosclerosis obliterans(ASO). Methods A total of 59 patients with Fontaine stage II-III ASO who underwent surgical treatment in Department of Vascular Surgery in our hospital from July 2020 to July 2022 were enrolled and randomly divided into control group with 30 patients (without regular walking training) and experimental group with 29 patients (regular progressive walking training), andthe two groups were compared in terms of the improvement inclaudication distance, ankle-brachial index (ABI),body mass index(BMI), and blood lipids after 6 months. Results There was no significant difference in the composition ratio of patients with different Fontaine stages between the two groups (P>0.05). Compared with the control group, the experimental group had significant improvements in claudication distance, ABI, and BMI after 6 months of training (P<0.05), and there was no significant difference in blood lipids between the experimental group and the control group due to the difference in blood lipid examination and the administration of lipid-lowering drugs (P>0.05). Conclusion Walking training can significantly improve BMI, ABI of bilateral limbs, and claudication distance in patients with Fontaine stage II-IIIASO, which provides a practical, simple, and economicalrehabilitation method for ASO patients. Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (17): 20-23.   Abstract （29）      PDF （1529KB）（92）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Prevention and Treatment of Cardiovascular Disease    2023, 13 (19): 31-34.   Abstract （34）      PDF （591KB）（92）       Knowledge map    Save Reference | Related Articles | Metrics

Select

Role of nursing pathway table intervention in improving the treatment compliance of elderly patients with diabetes and hypertension LI Xia, ZHANG De-li Prevention and Treatment of Cardiovascular Disease    2023, 13 (18): 58-61.   Abstract （40）      PDF （672KB）（90）       Knowledge map    Save Objective To investigate the effect of nursing pathway table intervention on the treatment compliance of elderly patients with diabetes and hypertension. Methods A total of 70 elderly patients with diabetes and hypertension who were treated in our hospital from January 2020 to January 2022 were enrolled and divided into groups A and B using a random number table, with 35 patients in each group. The patients in group A received routine nursing, and those in group B received nursing pathway table intervention in addition to the nursing regimen in group A. The two groups were compared in terms of blood pressure, blood glucose, treatment compliance, and quality of life based on 36-Item Short-Form Health Survey (SF-36). Results Compared with group A, group B had significantly lower levels of systolic pressure, diastolic pressure, fasting blood glucose, and 2-hour postprandial blood glucose before discharge (P<0.05). Group B had a significantly higher treatment compliance rate than group A (97.14% vs 74.29%, P<0.05). Group B also had a significantly higher SF-36 score than group A (P<0.05). Conclusion For elderly patients with diabetes and hypertension, nursing pathway table intervention can significantly reduce blood glucose and blood pressure, increase treatment compliance, and improve quality of life. Reference | Related Articles | Metrics